Cost effectiveness of natural health products: A systematic review of randomized clinical trials

Evidence-based Complementary and Alternative Medicine

Volumn 6, Issue 3, 2009, Pages 297-304

  Kennedy, Deborah A ^a   Hart, Jason ^a   Seely, Dugald ^a,b  

^a CANADIAN COLLEGE OF NATUROPATHIC MEDICINE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

CAM; Complementary and alternative medicine; Cost effectiveness; Natural health products; NHPs

Indexed keywords

ALPHA TOCOPHEROL; AMINO ACID; CHINESE DRUG; CRANBERRY EXTRACT; HERBACEOUS AGENT; HOMEOPATHIC AGENT; LACTULOSE; MINERAL; NATURAL HEALTH PRODUCT; NATURAL PRODUCT; OMEGA 3 FATTY ACID; PROBIOTIC AGENT; SENNA EXTRACT; UNCLASSIFIED DRUG;

ALLOPATHY; ALTERNATIVE MEDICINE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; CRANBERRY JUICE; CRITICALLY ILL PATIENT; ENTERIC FEEDING; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HUMAN; NAUSEA; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; URINARY TRACT INFECTION;

EID: 68949105733     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nem167     Document Type: Review

References (29)

1. Herman PM, Craig BM, Caspi O. Is complementary and alternative medicine (CAM) cost-effective? A systematic review. BMC Complement Altern Med 2005;5:11. (Pubitemid 41364083)
2. Hulme C, Long AF. Square pegs and round holes? A review of economic evaluation in complementary and alternative medicine. J Altern Complement Med 2005;11:179-188 (Pubitemid 40328133)
3. Snapshot Health Care Costs 101: Californian HealthCare Foundation, 2006: 24.
4. Health Care in Canada 2005: Canadian Institute for Health Information, 2005: 117.
5. Canada NDMAo. Canadian Self-Care Industry profile: Nonprescription Drug Manufacturers Association of Canada, 2003.
6. Contact with Alternative health care providers, by age group and sex, household population, aged 12 and over, Canada excluding territories, 2003: Statistics Canada, 2004: 5.
7. Contact with Alternative Health Care providers, by age group and sex, household population aged 12 and over, Canada excluding territories, 1994/95-1998/99: Statistics Canada, 2002: 5.
8. Barnes PM P-GE, McFann K, Nahin RL. Complementary and Alternative Use Among Adults, United States, 2002: US Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics, 2004: 19.
9. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569-1575
10. Ramsay CWM, Alexander J. Alternative Medicine in Canada: Use and Public Attitudes. Vancouver: The Fraser Institute, 1999, 31.
11. MacLennan AH, Myers SP, Taylor AW. The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Med J Aust 2006;184:27-31.
12. Ipsos/Reid. Baseline Natural Health Products Survey Among Consumers: Health Canada, 2005: 85.
13. Canada NDMAo. Self-Care: Making Canadians healthier: Nonprescription Drug Manufacturers Association of Canada, 2005, 9.
14. Canada NDMAo. HealthVision 1999/2000: Nonprescription Drug Manufacturers Association of Canada, 1999/2000.
15. Napper M, Newland J. Health Economics Information Resources: A Self-Study Course. Bethesda: U.S. National Library of Medicine, 2003.
16. Gunter MJ. The role of the ECHO model in outcomes research and clinical practice improvement. Am J Manag Care 1999;5 (4 Suppl):S217-24.
17. Kozma CM, Reeder CE, Schulz RM. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther 1993;15:1121-32; discussion 1120.
18. Senkal M, Zumtobel V, Bauer KH, Marpe B, Wolfram G, Frei A, et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 1999;134:1309-1316
19. Gianotti L, Braga M, Frei A, Greiner R, Di Carlo V. Health care resources consumed to treat postoperative infections: cost saving by perioperative immunonutrition. Shock 2000;14:325-330
20. Smedley F, Bowling T, James M, Stokes E, Goodger C, O'Connor O, et al. Randomized clinical trial of the effects of preoperative and postoperative oral nutritional supplements on clinical course and cost of care. Br J Surg 2004;91:983-990 (Pubitemid 39070811)
21. Davey PJ, Schulz M, Gliksman M, Dobson M, Aristides M, Stephens NG. Cost-effectiveness of vitamin E therapy in the treatment of patients with angiographically proven coronary narrowing (CHAOS trial). Cambridge Heart Antioxidant Study. Am J Cardiol 1998;82:414-417 (Pubitemid 28389936)
22. Franzosi MG, Brunetti M, Marchioli R, Marfisi RM, Tognoni G, Valagussa F. Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial. Pharmacoeconomics 2001;19:411-420 (Pubitemid 32319934)
23. Passmore AP, Wilson-Davies K, Stoker C, Scott ME. Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination. Br Med J 1993;307:769-771 (Pubitemid 23279322)
24. Paterson C, Ewings P, Brazier JE, Britten N. Treating dyspepsia with acupuncture and homeopathy: reflections on a pilot study by researchers, practitioners and participants. Complement Ther Med 2003;11:78-84. (Pubitemid 36764013)
25. Jones C, Palmer TE, Griffiths RD. Randomized clinical outcome study of critically ill patients given glutamine-supplemented enteral nutrition. Nutrition 1999;15:108-115 (Pubitemid 29072653)
26. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 2002;9:1558-1562
27. Andrews GJ. Addressing efficiency: economic evaluation and the agenda for CAM researchers. Complement Ther Clin Pract 2005;11:253-261
28. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet 1996;347:781-786 (Pubitemid 26091640)
29. Valagussa, et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447-455